Back
Inovio Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
INO
Sponsored
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
23
INO
Inovio Pharmaceuticals
Last Price:
5.53
Seasonality Move:
10.44%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!Inovio Pharmaceuticals Price Quote
$5.53
+0.01 (+-2.47%)
(Updated: November 8, 2024 at 4:20 AM ET)
Inovio Pharmaceuticals Key Stats
Sell
23
Inovio Pharmaceuticals (INO)
is a Sell
Day range:
$5.48 - $5.75
52-week range:
$3.89 - $14.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.48%
Volume:
299.3K
Avg. volume:
306.4K
1-year change:
20.73%
Market cap:
$143.3M
Revenue:
$832K
EPS:
$-5.11
How Much Does Inovio Pharmaceuticals Make?
Data Unavailable
Is Inovio Pharmaceuticals Growing As A Company?
-
What Is Inovio Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.55% -
What Is Inovio Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Inovio Pharmaceuticals Stock Price Performance
-
Did Inovio Pharmaceuticals Stock Go Up Last Month?
Inovio Pharmaceuticals share price went up by 3.56% last month -
Did INO's Share Price Rise Over The Last Year?
INO share price rose by 20.73% over the past 1 year
What Is Inovio Pharmaceuticals 52-Week High & Low?
-
What Is Inovio Pharmaceuticals’s 52-Week High Share Price?
Inovio Pharmaceuticals has traded as high as $14.75 over the past 52 weeks -
What Is Inovio Pharmaceuticals’s 52-Week Low Share Price?
Inovio Pharmaceuticals has traded as low as $3.89 over the past 52 weeks
Inovio Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Inovio Pharmaceuticals?
-
How Much Debt Does Inovio Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Inovio Pharmaceuticals Have?
Cash and short term investments quarterly total is $110.4M -
What Is Inovio Pharmaceuticals’s Book Value Per Share?
Book value per share is 3.73
Is Inovio Pharmaceuticals Cash Flow Positive?
-
What Is INO Cash Flow From Operations?
Cash flow from operations (TTM) is -$112.4M -
What Is Inovio Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $24.2M -
What Is Inovio Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is $69.8M
Inovio Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
INO return on invested capital is -91.32% -
What Is Inovio Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -70.72% -
What Is INO Return On Equity?
ROE is a measure of profitability and is -98.72%
Inovio Pharmaceuticals Earnings Date & Stock Price
-
What Is Inovio Pharmaceuticals's Stock Price Today?
A single share of INO can be purchased today for 5.52 -
What Is Inovio Pharmaceuticals’s Stock Symbol?
Inovio Pharmaceuticals trades on the nasdaq under the ticker symbol: INO -
When Is Inovio Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Inovio Pharmaceuticals is scheduled on November 14, 2024 -
When Is INO's next ex-dividend date?
Inovio Pharmaceuticals's next ex-dividend date is May 1, 2020 -
How To Buy Inovio Pharmaceuticals Stock?
You can buy Inovio Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Inovio Pharmaceuticals Competitors
-
Who Are Inovio Pharmaceuticals's Competitors?
Below is a list of companies who compete with Inovio Pharmaceuticals or are related in some way:
Inovio Pharmaceuticals Dividend Yield
-
What Is INO Dividend Yield?
Inovio Pharmaceuticals’s dividend yield currently is 0% -
What Is Inovio Pharmaceuticals’s Payout Ratio?
Inovio Pharmaceuticals’s payout ratio is 0% -
When Did Inovio Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is November 8, 2024 -
What Is Inovio Pharmaceuticals’s Dividend Per Share?
Inovio Pharmaceuticals pays a dividend of $0.00 per share
Inovio Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -8.02% |
Revenue: | -55.41% | -17.07% |
Analyst Recommendations
Buy Recommendations: | 2 |
---|---|
Hold Recommendations: | 3 |
Sell Recommendations: | 0 |
Price Target: | 15.75 |
Upside from Last Price: | 185.33% |